Treace Medical Concepts (TMCI) Payables (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Payables data on file, last reported at $15.3 million in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 15.41% year-over-year to $15.3 million; the trailing twelve-month figure through Mar 2026 stood at $15.3 million (up 15.41% YoY), and the FY2025 full-year result was $8.5 million, down 19.49% from the prior year.
• Payables for Q1 2026 stood at $15.3 million, up from $8.5 million in the prior quarter.
• Across five years, Payables topped out at $21.1 million in Q1 2024 and bottomed at $3.1 million in Q2 2022.
• The 5-year median for Payables is $10.5 million (2024), against an average of $11.8 million.
• The widest annual swing landed in 2024, when Payables jumped 316.65%; it then tumbled 37.26% in 2025.
• A 5-year view of Payables shows it stood at $8.7 million in 2022, then jumped by 36.54% to $11.8 million in 2023, then dropped by 11.09% to $10.5 million in 2024, then retreated by 19.49% to $8.5 million in 2025, then soared by 80.77% to $15.3 million in 2026.
• The last three Payables figures came in at $15.3 million (Q1 2026), $8.5 million (Q4 2025), and $17.9 million (Q3 2025), per Business Quant data.

Peer Comparison